These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2629126

  • 21. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease.
    Podhorecka M, Dmoszynska A, Rolinski J.
    Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335
    [Abstract] [Full Text] [Related]

  • 22. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 23. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.
    J Immunol; 1985 Mar 15; 134(3):1503-7. PubMed ID: 3918102
    [Abstract] [Full Text] [Related]

  • 24. [Natural killer cells lysing the blood B-lymphocytes of patients with chronic lympholeukemia].
    Khonina NA, Shubinskiĭ GZ.
    Eksp Onkol; 1988 Mar 15; 10(4):44-6. PubMed ID: 3263265
    [Abstract] [Full Text] [Related]

  • 25. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P, Zelen I, Ristic P, Baskic D, Popovic S, Arsenijevic N.
    Arch Med Res; 2009 Jul 15; 40(5):357-63. PubMed ID: 19766898
    [Abstract] [Full Text] [Related]

  • 26. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF, Inwards DJ, Lacy MQ, Markovic SN.
    Bone Marrow Transplant; 2001 Oct 15; 28(7):673-80. PubMed ID: 11704790
    [Abstract] [Full Text] [Related]

  • 27. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B, Portalès P, Thanh AD, Merlet S, Dereure O, Clot J, Corbeau P.
    Br J Dermatol; 2005 Apr 15; 152(4):690-6. PubMed ID: 15840100
    [Abstract] [Full Text] [Related]

  • 28. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.
    Lew F, Tsang P, Solomon S, Selikoff IJ, Bekesi JG.
    J Clin Lab Immunol; 1984 Jul 15; 14(3):115-21. PubMed ID: 6237206
    [Abstract] [Full Text] [Related]

  • 29. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
    Laso FJ, Madruga JI, Girón JA, López A, Ciudad J, San Miguel JF, Alvarez-Mon M, Orfao A.
    Hepatology; 1997 May 15; 25(5):1096-100. PubMed ID: 9141423
    [Abstract] [Full Text] [Related]

  • 30. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients.
    Schisselbauer JC, Silber R, Papadopoulos E, Abrams K, LaCreta FP, Tew KD.
    Cancer Res; 1990 Jun 15; 50(12):3562-8. PubMed ID: 2340505
    [Abstract] [Full Text] [Related]

  • 31. [Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis].
    Maruo Y.
    Hokkaido Igaku Zasshi; 1988 Jul 15; 63(4):521-33. PubMed ID: 2464533
    [Abstract] [Full Text] [Related]

  • 32. Defect of NK activity in children with untreated acute lymphocytic leukemia (ALL). I. Dependence on the blast count and phenotype, and response to exogenous and endogenous alpha-interferon.
    Gabrilovac J, Rajić L, Martin-Kleiner I, Osmak M, Batinić D, Tiefenbach A, Boranić M.
    J Clin Lab Immunol; 1989 May 15; 29(1):9-15. PubMed ID: 2628585
    [Abstract] [Full Text] [Related]

  • 33. Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS).
    Kimby E, Mellstedt H, Nilsson B, Björkholm M, Holm G.
    Leukemia; 1989 Jul 15; 3(7):501-4. PubMed ID: 2471902
    [Abstract] [Full Text] [Related]

  • 34. Defective natural killer cell activity in B-cell chronic lymphocytic leukaemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-alpha.
    Katrinakis G, Kyriakou D, Papadaki H, Kalokyri I, Markidou F, Eliopoulos GD.
    Acta Haematol; 1996 Jul 15; 96(1):16-23. PubMed ID: 8677756
    [Abstract] [Full Text] [Related]

  • 35. Effect of Astragulas membranaceus on natural killer cell activity and induction of alpha- and gamma-interferon in patients with Coxsackie B viral myocarditis.
    Yang YZ, Jin PY, Gúo Q, Wang QD, Li ZS, Ye YC, Shan YF, Zhao HY, Zhu JR, Pu SY.
    Chin Med J (Engl); 1990 Apr 15; 103(4):304-7. PubMed ID: 2167822
    [Abstract] [Full Text] [Related]

  • 36. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
    Boussiotis VA, Pangalis GA.
    Br J Haematol; 1991 Oct 15; 79 Suppl 1():30-3. PubMed ID: 1931705
    [Abstract] [Full Text] [Related]

  • 37. [NAD- and NADP-diaphorase activity in the peripheral blood lymphocytes of patients with the B-cell variant of chronic lympholeukemia].
    Fed'ko AA, Guseva SA, Tishchenko LM, Poliachenko LIu.
    Vrach Delo; 1991 Mar 15; (3):47-9. PubMed ID: 2042348
    [Abstract] [Full Text] [Related]

  • 38. Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia.
    McSweeney EN, Giles FJ, Worman CP, Jewel AP, Tsakona CP, Hoffbrand AV, Mehta AB, Newland AC, Cawley JC, Galvani D.
    Br J Haematol; 1993 Sep 15; 85(1):77-83. PubMed ID: 8251412
    [Abstract] [Full Text] [Related]

  • 39. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
    Demeter J, Paloczi K, Bibok G, Lehoczky D.
    Leukemia; 1992 Sep 15; 6 Suppl 3():41S-45S. PubMed ID: 1602826
    [Abstract] [Full Text] [Related]

  • 40. [Present possibilities of treatment of chronic B-cell lymphocytic leukemia].
    Belić A, Pejin D.
    Med Pregl; 1991 Sep 15; 44(9-10):423-8. PubMed ID: 1806799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.